What Is Nabota Botox and How Does It Treat Crow's Feet?
Nabota is a prescription medicine, specifically a purified form of botulinum toxin type A, that is injected into the muscles around the eyes to temporarily improve the appearance of moderate to severe crow's feet. It works by blocking the nerve signals that tell those specific muscles to contract, which smooths out the dynamic wrinkles that form from repeated smiling, squinting, and other facial expressions.
To understand how Nabota works, it's helpful to know a bit about the science behind the wrinkles it treats. Crow's feet, or lateral canthal lines, are a classic example of dynamic wrinkles. They are caused by the repeated contraction of the orbicularis oculi muscle, which is the sphincter muscle that encircles the eye and is responsible for blinking and squinting. Every time you smile or scrunch your eyes, this muscle contracts. Over years and thousands of repetitions, the skin above the muscle begins to crease permanently. Nabota's mechanism of action is highly targeted. The active ingredient, botulinum toxin type A, acts at the neuromuscular junction—the point where a motor nerve communicates with a muscle fiber. It cleaves a protein known as SNAP-25, which is essential for the release of acetylcholine, the neurotransmitter that signals the muscle to contract. By inhibiting this release, Nabota creates a temporary, controlled muscle relaxation. This relaxation allows the overlying skin to smooth out, reducing the visibility of the wrinkles.
The clinical journey of nabota botox is particularly noteworthy. Developed by the South Korean biopharmaceutical company Daewoong Pharmaceutical, it underwent rigorous clinical trials to demonstrate its safety and efficacy before gaining approval from various regulatory bodies worldwide. Its approval by the U.S. Food and Drug Administration (FDA) in 2019 was based on a robust clinical program. A key Phase 3 trial involved over 900 participants with moderate to severe crow's feet. The results were compelling, showing a significant improvement compared to a placebo. When measured by both investigators' assessments and patient self-reports, a vast majority of participants treated with Nabota achieved a improvement of at least one grade on a standardized wrinkle severity scale at maximum contraction just four weeks after injection. This data was crucial in establishing Nabota as a reliable and effective option for aesthetic practitioners and their patients.
When considering treatment, patients often want to know how Nabota compares to other well-known neuromodulators like Botox (onabotulinumtoxinA) and Dysport (abobotulinumtoxinA). While they all utilize the same core mechanism of action—botulinum toxin type A—there are subtle differences in their molecular structure, protein complex size, and unit potency that can influence clinical practice. The following table outlines some key characteristics:
| Characteristic | Nabota (prabotulinumtoxinA) | Botox (onabotulinumtoxinA) | Dysport (abobotulinumtoxinA) |
|---|---|---|---|
| Molecular Protein Complex | 900kDa | 900kDa | 500-900kDa |
| FDA Approval for Crow's Feet | Yes (2019) | Yes (2013) | Yes (2009) |
| Typical Onset of Action | 2-3 days | 2-3 days | 2-3 days |
| Peak Effect | ~4 weeks | ~4 weeks | ~4 weeks |
| Reported Duration | 3-4 months | 3-4 months | 3-4 months |
It is critical to understand that the units of measurement for Nabota, Botox, and Dysport are not interchangeable. A unit of Nabota is not equivalent to a unit of Botox or Dysport. Each product has its own unique potency and dosing guidelines. An experienced medical professional will determine the correct dosage and injection pattern based on the individual's facial anatomy, muscle strength, and desired outcome. Self-dosing or seeking treatment from unqualified individuals is extremely dangerous.
The actual treatment process is a precise medical procedure. A typical appointment for crow's feet treatment with Nabota begins with a comprehensive consultation. The practitioner will assess your facial structure, discuss your goals, and review your medical history to ensure you are a suitable candidate. On the day of treatment, the area around the eyes is cleansed. While some patients opt for a topical numbing cream, the procedure is generally well-tolerated as the needles used are exceptionally fine. The practitioner will then administer a series of small, shallow injections into the orbicularis oculi muscle. The number of injections per side can vary but often ranges from three to five. The entire process for both eyes usually takes only about 10 to 15 minutes.
Post-treatment care is straightforward but important for optimal results and safety. Patients are typically advised to remain upright for a few hours and avoid rubbing or massaging the treated area for at least 24 hours. This prevents the toxin from inadvertently spreading to adjacent muscles, which could lead to temporary side effects like a droopy eyelid (ptosis). Strenuous exercise should also be avoided for the first day. The effects of Nabota are not immediate. It takes a few days for the muscle relaxation to begin, with the full smoothing effect becoming most apparent after about one to two weeks. The results are temporary, typically lasting for three to four months. As muscle action gradually returns, the crow's feet will begin to reappear, and repeat treatments are necessary to maintain the smooth appearance.
Like all prescription medications, Nabota has potential side effects, though they are usually mild and transient when administered by a skilled professional. Common side effects specific to crow's feet treatment can include injection site reactions like redness, swelling, bruising, or tenderness. Headache can also occur. More specific to the eye area, some patients may experience temporary dryness or excessive tearing. The most significant risk, as mentioned, is the unintended spread of the toxin to nearby muscles, which can cause eyelid ptosis or an uneven smile. This underscores the paramount importance of choosing a qualified and experienced injector, such as a board-certified dermatologist or plastic surgeon, who has an in-depth understanding of facial anatomy.
Determining if you are a good candidate for Nabota involves several factors. Ideal candidates are generally adults in good health who are seeking to improve the appearance of dynamic crow's feet lines that are present when they animate their face. It is not designed for static wrinkles—lines that are visible when the face is completely at rest. Nabota is not recommended for women who are pregnant or breastfeeding, or for individuals with certain neurological disorders like myasthenia gravis or Lambert-Eaton syndrome. A thorough consultation with a medical professional is essential to assess suitability and discuss realistic expectations. The goal of treatment with Nabota and similar products is a natural, refreshed look—not a completely frozen or expressionless face. A skilled injector will aim to soften the wrinkles while preserving your ability to express emotions naturally.